Metabolomics LC-MS data supporting the publication: The broccoli-derived antioxidant sulforaphane changes the growth of gastrointestinal microbiota, allowing for the production of anti-inflammatory metabolites.
Sarah A. Marshall (1), Remy B. Young (2,3), Jessica M. Lewis (4), Emily L. Rutten (2,3), Jodee Gould (2,3), Christopher K. Barlow (5), Cristina Giogha (2,3), Vanessa R. Marcelino (2,3), Neville Fields (1), Elizabeth L. Hartland (2,3), Nichollas E. Scott (4), Samuel C. Forster (2,3) and Emily L. Gulliver (2,3)
Correspondence: Emily.gulliver@hudson.org.au
Affiliations:
(1) The Ritchie Centre, Department of Obstetrics and Gynaecology, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia
(2) Centre of Innate Immunity and Infectious Disease, Hudson Institute of Medical Research, Clayton, Victoria, Australia
(3) Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, 3800, Australia
(4) Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia
(5) Monash Proteomics & Metabolomics Facility, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia
https://doi.org/10.1016/j.jff.2023.105645
Toggle Full Description
Metabolomics LC-MS data supporting the publication: The broccoli-derived antioxidant sulforaphane changes the growth of gastrointestinal microbiota, allowing for the production of anti-inflammatory metabolites.
Sarah A. Marshall (1), Remy B. Young (2,3), Jessica M. Lewis (4), Emily L. Rutten (2,3), Jodee Gould (2,3), Christopher K. Barlow (5), Cristina Giogha (2,3), Vanessa R. Marcelino (2,3), Neville Fields (1), Elizabeth L. Hartland (2,3), Nichollas E. Scott (4), Samuel C. Forster (2,3) and Emily L. Gulliver (2,3)
Correspondence: Emily.gulliver@hudson.org.au
Affiliations:
(1) The Ritchie Centre, Department of Obstetrics and Gynaecology, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia
(2) Centre of Innate Immunity and Infectious Disease, Hudson Institute of Medical Research, Clayton, Victoria, Australia
(3) Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, 3800, Australia
(4) Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia
(5) Monash Proteomics & Metabolomics Facility, Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia
https://doi.org/10.1016/j.jff.2023.105645